Table 2.
Exposure |
Frequency |
Adjusted RR |
P-value |
|
---|---|---|---|---|
|
Case window |
(95% CI)†Control window |
|
|
N = 6,333 | N = 10,737 | |||
Any discharge |
687 (10.8%) |
849 (7.9%) |
1.40 (1.22 – 1.59) |
<0.001* |
Asthma-related discharge |
442 (7.0%) |
389 (3.6%) |
1.99 (1.65 – 2.39) |
<0.001* |
Non-asthma-related discharge |
273 (4.3%) |
495 (4.6%) |
0.88 (0.74 – 1.04) |
0.141 |
Respiratory-related discharge |
523 (8.3%) |
497 (4.6%) |
1.89 (1.60 – 2.22) |
<0.001* |
Respiratory-related, non-asthma discharge |
89 (1.4%) |
124 (1.2%) |
1.23 (0.90 – 1.68) |
0.199 |
Non-respiratory-related discharge | 189 (3.0%) | 381 (3.5%) | 0.78 (0.63 – 0.96) | 0.017* |
*Significant at 0.05 level.
†All RRs are adjusted for the following variables estimated in the 180 days prior to the start of the time window: number of asthma-related hospital admissions, outpatient services use, medication dispensations, number of dispensations of short-acting beta-agonists, inhaled corticosteroids, and combined inhaled corticosteroids and long-acting beta-agonists, as well as total number of hospital admissions, outpatient services use, medication dispensations, and the Charlson co-morbidity index.